Mrs Erin Bailey Evans, OTR | |
541 Deer Ridge Dr, Bayfield, CO 81122-9398 | |
(970) 903-0098 | |
Not Available |
Full Name | Mrs Erin Bailey Evans |
---|---|
Gender | Female |
Speciality | Occupational Therapist - Pediatrics |
Location | 541 Deer Ridge Dr, Bayfield, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497722888 | NPI | - | NPPES |
OT2175 | Medicaid | CO | |
A014 | Other | TRICARE | |
OT1270 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XP0200X | Occupational Therapist - Pediatrics | 2175 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Erin Bailey Evans, OTR 541 Deer Ridge Dr, Bayfield, CO 81122-9398 Ph: (970) 903-0098 | Mrs Erin Bailey Evans, OTR 541 Deer Ridge Dr, Bayfield, CO 81122-9398 Ph: (970) 903-0098 |
News Archive
Neuroscientists from Japan's Yamaguchi University today reported during the 66th annual scientific meeting of the American Epilepsy Society (AES) that chronic focal brain cooling suppresses seizures during wakefulness and achieves the effect without significantly affecting brain function. Their research, and that of others in the field, provides critical evidence that this approach to seizure control has reached a stage where testing in humans will soon be possible.
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
The study, published in CDC's Morbidity and Mortality Weekly Report (MMWR), underlies the importance of evaluating the impact of strategies addressing adult mental health status during the pandemic. This way, these can help plan strategies and interventions for the affected groups.
Genzyme, a Sanofi company, announced it has received a Refuse to File letter from the U.S. Food and Drug Administration (FDA) in response to the supplemental Biologics License Application (sBLA) for the approval of LEMTRADA (alemtuzumab) as a treatment for relapsing multiple sclerosis.
The popular dietary supplement vitamin E, loaded into special medicated contact lenses, can keep glaucoma medicine near the eye - where it can treat that common disease- almost 100 times longer than possible with current commercial lenses, scientists reported here today.
› Verified 4 days ago
Susan Livingston, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 East South Street, Bayfield, CO 81122 Phone: 970-884-3259 Fax: 970-884-2842 |